What is LOPJLB’s current signal on FATE?

LOPJLB’s latest quantitative signal on Fate Therapeutics, Inc. (FATE) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is FATE in?

Fate Therapeutics, Inc. (FATE) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Fate Therapeutics, Inc. based / listed?

Fate Therapeutics, Inc. is based in US, listed on NASDAQ.

Fate Therapeutics, Inc. (FATE)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.13-0.93%Close

SELLCRISIS · day 2

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $248M
Beta: 2.53
P/E (TTM): -2.18

Short % float: 9.21%
Days to cover: 10.5
SI change: +3.0%

1W: -7.39%
1M: -12.70%

vs SPY 1W: -8.95%
vs SPY 1M: -14.47%

Industry peers

FMP comparable companies · ranked by market cap

VORSELLVor Biopharma Inc.$992MCRISISQ -13$18.31+1.86%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating advanced, programmed cellular immunotherapies. These innovative treatments are designed to combat cancer and various immune disorders across the globe. A significant portion of its…

Employees: 161
Headquarters: US
Founded: 2013
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 116.6M
Float: 87.4%

fatetherapeutics.com ↗

Key executives

Bahram Valamehr — President, Chief Executive Officer & Director

Cindy R. Tahl — Chief Legal & Compliance Officer and Corporate Secretary

Kamal Adawi — CFO & Treasurer

SEC filings

EDGAR · CIK 14343160 · FATE

Analyst consensus

Buy

Bullish1651.6%

Neutral1341.9%

Bearish26.5%

L $3.50Avg $5.63H $8.00

Target$5.63+164.32%

Last$2.13

Key stats

Industry peers

Prediction markets

Company news